Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status

By Kelland L.R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 12, 2000-12 ,pp. : 2903-2911

Informa Healthcare

Access to resources Recommend Favorite

Flavopiridol, the First Cyclin-Dependent Kinase Inhibitor: Recent Advances in Combination Chemotherapy

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 11, 2010-10 ,pp. : 1058-1070

Bentham Science Publishers

Access to resources Recommend Favorite

Phase II Study of Perifosine in Previously Untreated Patients with Metastatic Melanoma

By Ernst D   Eisenhauer Elizabeth   Wainman Nancy   Davis Mary   Lohmann Reinhard   Baetz Tara   Belanger Karl   Smylie Michael  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 569-575

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial

By Li Tianhong  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 741-748

Springer Publishing Company

Access to resources Recommend Favorite

Multi-centre Phase II trial of the polyamine synthesis inhibitor SAM486A (CGP48664) in patients with metastatic melanoma

By Millward Michael   Joshua Anthony   Kefford Rick   Aamdal Steinar   Thomson Damien   Hersey Peter   Toner Guy   Lynch Kevin  

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 253-256

Springer Publishing Company

Access to resources Recommend Favorite